Recently released by MD+DI and ITG Market Research, the "Medical Device Outsourcing Landscape Study" found that 41% of the 853 medical device professionals that responded expect their companies will “increase use of contract services” over the next five years. Another MD+DI article referenced that many believe the industry is headed for change and uncertainty.  Medical device companies are facing increasing pressure in cost, time to market, and a tougher regulatory environment.

As a medical device CRO, we appreciate the medical device industry sector and look forward to its continued growth and expansion. So, a recent report that highlights the industry’s progression and outsourcing future caught our attention. While there looms uncertainty regarding the medical device tax and the effect on companies, one thing is certain - the medical device industry is experiencing tremendous growth.

MarketWatch recently had a news-release on “Markets and Outsourcing for Clinical Activities.” In the article, it’s noted that while in the US and Europe costs are continuing to rise for clinical activities, sales are not growing- or growing at an insignificant rate. This is in stark contrast to emerging markets, where the opposite seems to hold true. Not surprisingly,  this leads to  more medical device organizations evaluating an expansion of their clinical programs into emerging markets to cut costs and boost sales.